Procter & Gambl...
Health Care: Drugs
Endocyte Inc. (ECYT: NASDAQ)
$14.02 0.00 | 0.00%
05/24/13 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 14.02 |
| 52 Week High | 15.36 |
| 52 Week Low | 6.23 |
| Avg. Daily Vol. (Mil) | 0.29 |
| Beta (3 year) | 1.22 |
| Share Related Items | |
| Mkt Cap (Mil) | 504.34 |
| Shares Out (Mil) | 35.97 |
| Float (Mil) | 30.47 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 2.20 |
| Current Ratio | 2.30 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 10.25 |
| Price/Book | 5.20 |
| Price/Cash Flow | -24.30 |
| Per Share Data | |
| Earnings | -0.31 |
| Sales | 1.37 |
| Book Value | 2.69 |
| Cash Flow | -0.58 |
| Business Summary | |
|---|---|
| Endocyte Inc is a biopharmaceutical Company developing targeted therapies for the treatment of cancer and inflammatory diseases. It uses its proprietary technology to create novel small molecule drug conjugates, or SMDCs, and companion imaging diagnose. | |
| General Information | |
| 3000 Kent Avenue
Suite A1-100 West Lafayette, IN 47906 |
|
| www.endocyte.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 71 | |
| CEO: Mr. P. Ron Ellis | |
| Short Interest | |
| Current Month (Mil) | 2.29 |
| Previous Month (Mil) | 2.32 |
| Short Interest Ratio (Days) | 7.00 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -10.60 |
| Return on Investments | -21.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | -23.40 |
| Profit Margin | -43.00 |
Portfolios with ECYT
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Setting Up...
- UserSmart Growth
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorEarnings Short Squeeze Play...
- ContributorStocks With Big Insider Buy...
- ContributorStocks Rising On Unusal Vol...
- Contributor8 Health Care Stocks With R...
Latest ECYT Headlines from TheStreet
- Endocyte Appoints Scot L. Harper, Ph.D., As Vice President Of Clinical Operations 05.07.13 | 04:05 pm
- Endocyte Reports First Quarter 2013 Financial Results And Business Update 05.02.13 | 04:05 pm
- Clinical Study Shows Involvement Of Activated Macrophages In Osteoarthritis, Identified By Endocyte's Etarfolatide 04.25.13 | 05:04 pm
- Endocyte, Inc. Announces Annual Stockholders' Meeting 04.22.13 | 04:04 pm
- Endocyte Announces First Quarter 2013 Earnings Conference Call 04.18.13 | 04:04 pm
- Endocyte Announces Presentations At AACR Annual Meeting 2013 04.03.13 | 04:04 pm
- Endocyte To Present At The Future Leaders In The Biotech Industry Conference 04.01.13 | 08:04 am
- Endocyte To Webcast Investor And Analyst Day In New York City 03.18.13 | 09:03 am
- Endocyte's Investigational Diagnostic Imaging Agent Etarfolatide Identifies Ovarian Cancer And Non-Small Cell Lung Cancer Patients Most Likely To Benefit From Folate Receptor-Targeted Treatment, New Analysis Shows 03.01.13 | 03:03 pm
- Endocyte To Present At Upcoming Conferences In March 02.26.13 | 04:02 pm
Press Releases for ECYT
- Merck And Endocyte Announce Acceptance For Review Of European Marketing Authorization Applications For Vintafolide And Companion Diagnostic Etarfolatide For Folate-Receptor Positive Platinum-Resistant Ovarian Cancer - Business Wire 11.27.12 | 08:11 am
- Merck And Endocyte Enter Exclusive Worldwide Agreement To Develop And Commercialize Phase III Cancer Candidate Vintafolide (EC145) - Business Wire 04.16.12 | 07:04 am
Partner Headlines for ECYT
- Company News for April 17, 2012 - Corporate Summary - Zacks 04.17.12 | 10:04 am
- Morning Market Movers - Benzinga 04.16.12 | 09:04 am
- Top 30 Rallying Small Cap Stocks With Significant Institutional Buying - Seeking Alpha 06.29.11 | 09:06 am
- Company News for April 27, 2011 - Corporate Summary - Zacks 04.27.11 | 10:04 am
- 5 Oncology Drugs Available for Partnering - Seeking Alpha 04.27.11 | 09:04 am
- 7 Diverse U.S. IPOs Test Investor Appetites This Week - Seeking Alpha 02.13.11 | 06:02 am
